SAMUEL ADAWARA

Mr. SAMUEL ADAWARA


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2020 in Beni-Suef University Journal of Basic and Applied Sciences
Verified
Journal Article
Open access
PDF file
SASAMUEL ADAWARA
SAMUEL ADAWARA
GSGideon Adamu Shallangwa
Gideon Adamu Shallangwa
PMPaul Andrew Mamza
Paul Andrew Mamza
AIAbdulkadir Ibrahim
Abdulkadir Ibrahim
Background: Dengue fever is a key public health unease in various tropical and sub-tropical regions. The improvement of existing agents that can inhibit the dengue virus is therefore of utmost importance. In this work, the QSAR study was carried out on 25 molecules of phthalazinone derivatives which have been reported to possess excellent dengue virus inhibitory activity. Density functional computational technique was used in the optimisation of the molecules with the basis set at theory level (B3LYP, 6-31G*) respectively. The multiple linear regression (MLR) model was built using genetic function approximation (GFA) in the material studio software package. Also, in this study, molecular docking simulation was carried between dengue virus serotype 2 protease (PDB CODE: 6mol) and some selected phthalazinone derivatives (compounds 1, 2, 7, 11, and 21). Results: The model was robust as evidenced by validation and robustness statistical parameter which include predicted R2pred., adjusted R2adj., cross-validated Q2 and R2 regression coefficient, etc (R2pred. = 0.71922, R2adj. = 0.939699, Q2CV = 0.905909, R2 = 0.955567) respectively. The molecular docking studies conducted in this study have outlined the binding affinities of the selected compounds (1, 2, 7 11, and 21) which are all in good correlation with their respective pIC50 values. The free binding affinities of the selected compounds were found to be (− 8.7, − 8.8, − 8.7, − 8.3, and − 8.9 kcal/mol) respectively, compound 21 with the binding affinity of − 8.9 kcal/mol had the best binding free energy with the protease relative to other compounds under consideration. Conclusion: The MLR-GFA model study alongside with the molecular docking analysis has essentially provided a valuable and in-depth understanding as well as knowledge for the development of novel chemical compounds with enhanced inhibitory potential against the dengue virus serotype 2 (DNV-2). Hence, the developed model can be applicable in predicting the anti-dengue activity of a new set of chemical compounds that fall within its applicability domain.

14 March 2022 in Bulletin of the National Research Centre
Verified
Journal Article
Open access
PDF file
SASAMUEL ADAWARA
SAMUEL ADAWARA
GSGideon Adamu Shallangwa
Gideon Adamu Shallangwa
PMPaul Andrew Mamza
Paul Andrew Mamza
IAIbrahim Abdulkadir
Ibrahim Abdulkadir
Background: Dengue virus (DENV) infection is spreading rapidly, especially in the subtropical and tropical regions, placing a huge percentage of the global population at risk and causing repeated outbreaks. DENV protease inhibition has been suggested as a viable therapeutic strategy. Using a computer-aided design approach and the structure-based drug design approach, ten 1, 2, 4-oxadiazole derivatives were designed based on the lead template (34) from our prior study. The design involved the substitution at the phenyl pharmacophore of the lead with methylamine, hydroxyl, and methoxy groups. To compare the anti-DENV efficacy of the optimized designed compounds to the template and other DENV referenced inhibitors targeting the NS-5 protease (PDB ID: 5K5M), they were docked with the DENV NS-5 protease. In silico, ADME characteristics and drug-likeness were also assessed for the compounds. Results: The molecular docking scores of the designed 1, 2, 4-oxadiazole derivatives varied from − 19.091 to − 29.61 kcal/mol, with excellent hydrogen bond energies in the range of − 3.402 to − 9.0128 kcal/mol, compared to the lead with a score of − 19.10 kcal/mol, and the hydrogen bond energy is − 3.10 kcal/mol, both of which are lower than those of the proposed compounds. Ferentinide, S-adenosyl-l-homocysteine, and Ribavirin were found to have lower binding scores of − 15.8137, − 16.5362, and − 12.446 kcal/mol, respectively, with hydrogen bond energies of − 4.2659, − 10.4372, and − 7.2995 kcal/mol. The developed compounds all followed Lipinski's criteria, meaning they were highly bioavailable, had no potential carcinogenic or mutagenic properties, and posed no concern of cardiovascular toxicity based on the ADMET profile. Conclusion: The proposed oxadiazole derivative interacted better with DENV protease (NS-5) than the lead inhibitor as well as the conventional inhibitors. Compounds 34a and 34b had the best ligand-protease interaction and gave the lowest free energy at − 26.54 and − 29.612 kcal/mol, respectively. Hence, they could be suggested as potential therapeutic candidates to inhibit NS-5 RdRp protease. This study has revealed the anti-DENV action of the designed compounds, indicating that synthesis and in vivo studies into their efficacy and mechanism are warranted.

18 June 2021 in Chemistry Africa
Verified
Journal Article
Closed access
PDF file
SASAMUEL ADAWARA
SAMUEL ADAWARA
GSGideon Adamu Shallangwa
Gideon Adamu Shallangwa
PMPaul Andrew Mamza
Paul Andrew Mamza
AIAbdulkadir Ibrahim
Abdulkadir Ibrahim

29 April 2022 in Chemistry Africa
Verified
Journal Article
Closed access
PDF file
SASAMUEL ADAWARA
SAMUEL ADAWARA
GSGideon Adamu Shallangwa
Gideon Adamu Shallangwa
PMPaul Andrew Mamza
Paul Andrew Mamza
IAIbrahim Abdulkadir
Ibrahim Abdulkadir

1 September 2021 in Scientific African
Verified
Journal Article
Open access
SASAMUEL ADAWARA
SAMUEL ADAWARA
GSGideon Adamu Shallangwa
Gideon Adamu Shallangwa
PMPaul Andrew Mamza
Paul Andrew Mamza
AIAbdulkadir Ibrahim
Abdulkadir Ibrahim

23 March 2025 in Discover Chemistry
Verified
Journal Article
Open access
PDF file
SEStephen Ejeh
Stephen Ejeh
AAAbduljelil Ajala
Abduljelil Ajala
SASAMUEL ADAWARA
SAMUEL ADAWARA
SOSABITU OLASUPO
SABITU OLASUPO
ZIZakari Ya'u Ibrahim
Zakari Ya'u Ibrahim
UAUsman Abdulfatai
Usman Abdulfatai
One of the most prevalent genetic conditions is sickle cell disease (SCD), a multiorgan condition that impacts about 15 million people around the globe. The current standard of care for SCD mainly consists of hydroxyurea therapy or supportive care, which includes hydration, blood transfusions, and pain control. The FDA recently approved strategies that lower the frequency of vaso-occlusive crisis (VOC) events, including the monoclonal P-selectin and the small molecule L-glutamine. The search for drugs that bind to Hb and alter the oxygenation state allostery has been a key therapeutic area for SCD. In this study, computational methods such as in silico screening, pharmacokinetic evaluation, DFT study, and molecular dynamic simulation were used to identify lead compounds as natural antisickling agents. The idea was to search PubChem databases for novel bioactive plant compounds with the potential to prevent SCD effectively. The PubChem databases were screened based on the binding energy (BE), pharmacokinetics properties, DFT study, and MD simulation, and 3 molecules with PUBCHEM_CID 20684853, 44461326, and 137225065 out of the 157 compounds examined were identified as active candidate hits with BE of − 177.35 kcal, − 175.11 kcal, and − 182.13 kcal, respectively, as compared to − 173.08 kcal of P-Selectin, which indicated that it is more stable and requires more energy to dissociate. When compared to P-Selectin as the standard drug, these molecules showed the best pharmacokinetic properties and potency.